The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza).
 
Sara Bleve
No Relationships to Disclose
 
Francesco Ravera
No Relationships to Disclose
 
Silvia Rodrigues
No Relationships to Disclose
 
Mohamed Omar
No Relationships to Disclose
 
Emilio Francesco Giunta
No Relationships to Disclose
 
Filippo Pederzoli
No Relationships to Disclose
 
Hubert Pakula
No Relationships to Disclose
 
Amelia Altavilla
No Relationships to Disclose
 
Nicole Brighi
No Relationships to Disclose
 
Giorgia Gurioli
No Relationships to Disclose
 
Maria Concetta Cursano
No Relationships to Disclose
 
Chiara Casadei
No Relationships to Disclose
 
Cristian Lolli
No Relationships to Disclose
 
Giuseppe Schepisi
No Relationships to Disclose
 
David M. Nanus
Consulting or Advisory Role - AstraZeneca; Janssen Scientific Affairs
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Exelixis (Inst); immumedics (Inst); Janssen (Inst); Novartis (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
 
Pier VItale Nuzzo
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Ipsen; Pfizer
 
Massimo Loda
No Relationships to Disclose